RETROPHIN, INC. Trademarks
Address: Please login to see owner's address
Entity Type: Corporation
Approximately 4 trademarks found.
RETROPHIN
Research and development of pharmaceuticals for the treatment of rare diseases;research and development for the treatment of hypertension, kidney...
Current Owner: TRAVERE THERAPEUTICS, INC.
Status: CANCELLED - SECTION 8
Filed on: 2014-09-11
RETROPHIN
Pharmaceutical preparations for the treatment of catastrophic diseases, namely, focal segmental glomerulosclerosis, pantothenate kinase-associated...
Current Owner: Retrophin, Inc.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2013-08-07
RETROPHIN
Pharmaceutical preparations for the treatment of catastrophic diseases, namely, focal segmental glomerulosclerosis, pantothenate kinase-associated...
Current Owner: Retrophin, Inc.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2013-08-07
VECAMYL
Pharmaceutical preparations for the treatment of cardiovascular, neurological and psychiatric disorders
Current Owner: TILDE SCIENCES LLC
Status: SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Filed on: 2011-03-28
